| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
immunoglobulin heavy constant delta | 0.722 | 0.346 |
|
disease | 0.030 | None | 1.000 | 2 | 0 | 2002 | 2012 | |||||||||
|
immunoglobulin heavy variable 3-21 | 0.780 | 0.192 |
|
disease | 0.600 | None | 0.947 | 1 | 0 | 2005 | 2018 | |||||||||
|
immunoglobulin heavy constant mu | 0.644 | 0.654 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
T cell receptor delta locus | 0.650 | 0.692 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | |||||||||
|
T cell receptor gamma locus | 0.631 | 0.538 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 1986 | 2002 | |||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
disease | 0.700 | None | 0.966 | 3 | 0 | 1998 | 2019 | ||||||||
|
marker of proliferation Ki-67 | 0.431 | 0.808 | 1.3E-28 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 1995 | 2016 | ||||||||
|
Fc receptor like 3 | 0.612 | 0.769 | 6.0E-21 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2008 | 2011 | ||||||||
|
solute carrier family 28 member 1 | 0.686 | 0.538 | 5.7E-20 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
membrane metalloendopeptidase | 0.407 | 0.808 | 1.5E-18 |
|
disease | 0.080 | None | 0.875 | 1 | 0 | 1991 | 2013 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.100 | None | 1.000 | 2 | 0 | 2004 | 2019 | ||||||||
|
Fc receptor like 5 | 0.722 | 0.462 | 4.6E-17 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
disease | 0.050 | None | 1.000 | 1 | 0 | 1998 | 2008 | ||||||||
|
solute carrier family 29 member 2 | 0.653 | 0.577 | 3.2E-14 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2005 | 2008 | ||||||||
|
Fc fragment of IgE receptor II | 0.560 | 0.654 | 7.6E-12 |
|
disease | 0.100 | None | 1.000 | 3 | 0 | 1991 | 2019 | ||||||||
|
major histocompatibility complex, class I, G | 0.461 | 0.769 | 1.4E-11 |
|
disease | 0.060 | None | 1.000 | 3 | 0 | 2003 | 2008 | ||||||||
|
Fc receptor like 2 | 0.861 | 0.192 | 1.5E-11 |
|
disease | 0.030 | None | 1.000 | 2 | 0 | 2008 | 2009 | ||||||||
|
5'-nucleotidase ecto | 0.436 | 0.885 | 2.3E-11 |
|
disease | 0.050 | None | 0.800 | 1 | 0 | 1998 | 2018 | ||||||||
|
purinergic receptor P2X 7 | 0.450 | 0.808 | 3.3E-11 |
|
disease | 0.590 | None | 0.700 | 1 | 0 | 2000 | 2016 | ||||||||
|
collagen type XVIII alpha 1 chain | 0.449 | 0.808 | 1.7E-10 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
CD5 molecule | 0.682 | 0.308 | 2.3E-10 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 1986 | 2008 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.330 | None | 1.000 | 1 | 0 | 2004 | 2019 | ||||||||
|
T cell leukemia/lymphoma 1A | 0.558 | 0.500 | 5.7E-10 |
|
disease | 0.100 | None | 0.988 | 3 | 0 | 1988 | 2020 | ||||||||
|
Fc receptor like 4 | 0.670 | 0.500 | 7.9E-10 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
lipoprotein lipase | 0.474 | 0.808 | 1.3E-09 |
|
disease | 0.100 | None | 0.923 | 2 | 0 | 2005 | 2018 |